Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001–12
Samer A. Srour(Oklahoma City VA Health Care System), Graça M. Dores(United States Food and Drug Administration), Lindsay M. Morton(National Cancer Institute), Susan S. Devesa(National Institutes of Health), David P. Check(National Institutes of Health), Martha S. Linet(National Institutes of Health), Rochelle E. Curtis(National Institutes of Health)
Cited by 183
Related Papers
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k
2016 US lymphoid malignancy statistics by World Health Organization subtypes
|CA A Cancer Journal for Clinicians|2016|1.1k
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
|JNCI Journal of the National Cancer Institute|2005|830